These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22573639)

  • 1. Diffusion-weighted imaging characteristics of biopsy-proven demyelinating brain lesions.
    Abou Zeid N; Pirko I; Erickson B; Weigand SD; Thomsen KM; Scheithauer B; Parisi JE; Giannini C; Linbo L; Lucchinetti CF
    Neurology; 2012 May; 78(21):1655-62. PubMed ID: 22573639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical idiopathic inflammatory demyelinating lesions (IIDL): conventional and diffusion-weighted MR imaging (DWI) findings in 42 cases.
    Koelblinger C; Fruehwald-Pallamar J; Kubin K; Wallner-Blazek M; van den Hauwe L; Macedo L; Puchner SB; Thurnher MM
    Eur J Radiol; 2013 Nov; 82(11):1996-2004. PubMed ID: 23993757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted MR imaging in the preoperative assessment of brain abscesses.
    Leuthardt EC; Wippold FJ; Oswood MC; Rich KM
    Surg Neurol; 2002 Dec; 58(6):395-402; discussion 402. PubMed ID: 12517619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumefactive demyelinating lesions: a retrospective cohort study in Thailand.
    Ongphichetmetha T; Aungsumart S; Siritho S; Apiwattanakul M; Tanboon J; Rattanathamsakul N; Prayoonwiwat N; Jitprapaikulsan J
    Sci Rep; 2024 Jan; 14(1):1426. PubMed ID: 38228919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms.
    Mabray MC; Cohen BA; Villanueva-Meyer JE; Valles FE; Barajas RF; Rubenstein JL; Cha S
    AJR Am J Roentgenol; 2015 Nov; 205(5):1075-85. PubMed ID: 26496556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrimination of capsular stage brain abscesses from necrotic or cystic neoplasms using diffusion-weighted magnetic resonance imaging.
    Fertikh D; Krejza J; Cunqueiro A; Danish S; Alokaili R; Melhem ER
    J Neurosurg; 2007 Jan; 106(1):76-81. PubMed ID: 17236491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADC measurements in various patterns of multiple sclerosis lesions.
    Phuttharak W; Galassi W; Laopaiboon V; Laopaiboon M; Hesselink JR
    J Med Assoc Thai; 2006 Feb; 89(2):196-204. PubMed ID: 16579006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted imaging of fungal cerebral infection.
    Gaviani P; Schwartz RB; Hedley-Whyte ET; Ligon KL; Robicsek A; Schaefer P; Henson JW
    AJNR Am J Neuroradiol; 2005 May; 26(5):1115-21. PubMed ID: 15891169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of diffusion-weighted imaging and in vivo proton magnetic resonance spectroscopy in the differential diagnosis of ring-enhancing intracranial cystic mass lesions.
    Mishra AM; Gupta RK; Jaggi RS; Reddy JS; Jha DK; Husain N; Prasad KN; Behari S; Husain M
    J Comput Assist Tomogr; 2004; 28(4):540-7. PubMed ID: 15232388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histogram analysis of apparent diffusion coefficient maps for differentiating primary CNS lymphomas from tumefactive demyelinating lesions.
    Lu SS; Kim SJ; Kim N; Kim HS; Choi CG; Lim YM
    AJR Am J Roentgenol; 2015 Apr; 204(4):827-34. PubMed ID: 25794073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging features of idiopathic granulomatous mastitis: is there any contribution of diffusion-weighted imaging in the differential diagnosis?
    Yilmaz R; Demir AA; Kaplan A; Sahin D; Ozkurt E; Dursun M; Acunas G
    Radiol Med; 2016 Nov; 121(11):857-866. PubMed ID: 27406630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility-weighted imaging provides complementary value to diffusion-weighted imaging in the differentiation between pyogenic brain abscesses, necrotic glioblastomas, and necrotic metastatic brain tumors.
    Lai PH; Chung HW; Chang HC; Fu JH; Wang PC; Hsu SH; Hsu SS; Lin HS; Chuang TC
    Eur J Radiol; 2019 Aug; 117():56-61. PubMed ID: 31307653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI predictors for the conversion from contrast-enhancing to iron rim multiple sclerosis lesions.
    Wenzel N; Wittayer M; Weber CE; Schirmer L; Platten M; Gass A; Eisele P
    J Neurol; 2022 Aug; 269(8):4414-4420. PubMed ID: 35332392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-weighted MRI in inflammatory renal lesions: all that glitters is not RCC!
    Goyal A; Sharma R; Bhalla AS; Gamanagatti S; Seth A
    Eur Radiol; 2013 Jan; 23(1):272-9. PubMed ID: 22797980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiating hepatic abscess from malignant mimickers: value of diffusion-weighted imaging with an emphasis on the periphery of the lesion.
    Park HJ; Kim SH; Jang KM; Lee SJ; Park MJ; Choi D
    J Magn Reson Imaging; 2013 Dec; 38(6):1333-41. PubMed ID: 23559325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern of T2 hypointensity associated with ring-enhancing brain lesions can help to differentiate pathology.
    Schwartz KM; Erickson BJ; Lucchinetti C
    Neuroradiology; 2006 Mar; 48(3):143-9. PubMed ID: 16447037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain abscess and cystic brain tumor: discrimination with dynamic susceptibility contrast perfusion-weighted MRI.
    Erdogan C; Hakyemez B; Yildirim N; Parlak M
    J Comput Assist Tomogr; 2005; 29(5):663-7. PubMed ID: 16163039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restricted diffusion within ring enhancement is not pathognomonic for brain abscess.
    Hartmann M; Jansen O; Heiland S; Sommer C; Münkel K; Sartor K
    AJNR Am J Neuroradiol; 2001 Oct; 22(9):1738-42. PubMed ID: 11673170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-weighted imaging in acute demyelinating myelopathy.
    Zecca C; Cereda C; Wetzel S; Tschuor S; Staedler C; Santini F; Nadarajah N; Bassetti CL; Gobbi C
    Neuroradiology; 2012 Jun; 54(6):573-8. PubMed ID: 21743997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can diffusion-weighted imaging distinguish between benign and malignant pediatric liver tumors?
    Caro-Domínguez P; Gupta AA; Chavhan GB
    Pediatr Radiol; 2018 Jan; 48(1):85-93. PubMed ID: 28921384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.